QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
Free Trial

Health insurer UnitedHealth trumps 4Q profit expectations

Written by The Associated Press
January 15, 2020

UnitedHealth Group’s net income jumped 16% in the fourth quarter, as the nation’s biggest health insurer ended 2019 by topping Wall Street earnings expectations again.

The Minnentonka, Minnesota, company also reaffirmed a forecast for 2020 earnings that it first laid out last month.

Should you invest $1,000 in UnitedHealth Group right now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
UnitedHealth Group (UNH)
4.9597 of 5 stars		$502.48+1.9%1.50%30.71Moderate Buy$569.68
Compare These Stocks  Add These Stocks to My Watchlist 

More From MarketBeat
Healthcare Takes A Big Step Forward With The Help Of AI
from The Bull Report
Top Ten Brokerages You Can Trust
from MarketBeat
The Best AI Stock to Own in the World Today is Trading for Just $25
from Banyan Hill Publishing
7 Best Stocks to Own Right Now
from MarketBeat
Biden’s $374B Giveaway Into This Sector
from DTI
15 REITs That Wall Street Analysts Love in Today's Market
from MarketBeat
The #1 Crypto for 2024
from InvestorPlace
7 Space Stocks Growth-Oriented Investors Can Buy Now
from MarketBeat

Featured Articles and Offers

Recent Videos

Easy Growth Over for Tesla, Stock Driving Lower
Easy Growth Over for Tesla, Stock Driving Lower
Johnson & Johnson’s Dip is a Strategic Buy Point for Investors
Johnson & Johnson's Dip is a Strategic Buy Point for Investors
7 Cheap Dividend Stocks Offering Value and Price Upside
7 Cheap Dividend Stocks Offering Value and Price Upside
Early Stage-Investing: Spot Top Startups and Secure the Best Valuations
Early Stage-Investing: Spot Top Startups and Secure the Best Valuations
Search Headlines: